|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|
| Cash (used in)/provided by operating activities: | ||
| Net income | ||
| Adjustments to reconcile net income to cash (used in)/provided by operating activities: | ||
| Depreciation and amortization | ||
| Restructuring and other (income)/charges | ||
| Impairment charges | ||
| Deferred income taxes | ||
| Share-based compensation | ||
| Change in investments in trust fund securities | ||
| Equity in net loss of unconsolidated affiliates | ||
| Deferred financing fee amortization | ||
| Loss on asset disposal | ||
| Other gain, Blue Chip Swap | ||
| Other non-cash adjustments | ||
| Changes in operating assets and liabilities: | ||
| Trade receivables, net | ||
| Changes in deferred compensation | ||
| Inventories | ||
| Accounts payable, trade and other | ||
| Contract liability - short-term | ||
| Contract liability - long-term | ||
| Income taxes | ||
| Allkem Livent Merger | ||
| Total income taxes | ||
| Change in prepaid and other current assets and other assets | ||
| Change in accrued and other liabilities and other long-term liabilities | ||
| Net cash (used in)/provided by operating activities | ||
| Cash used in investing activities: | ||
| Capital expenditures | ||
| Investments in Livent NQSP securities | ||
| Cash & cash equivalents | ||
| Allkem Livent Merger | ||
| Nemaska Lithium | ||
| Total cash & cash equivalents | ||
| Investment in-transit - Nemaska Lithium | ||
| Proceeds from Blue Chip Swap, net of purchases | ||
| Investments in unconsolidated affiliates | ||
| Other investing activities | ||
| Net cash used in investing activities | ||
| Cash provided by/(used in) financing activities: | ||
| Proceeds from Revolving Credit Facility | ||
| Repayments of Revolving Credit Facility | ||
| Payments of financing fees | ||
| Proceeds from issuance of common stock - incentive plans | ||
| Repayment of QLP Note | ||
| Payments of underwriting fees and expenses - Offering | ||
| Proceeds from Offering | ||
| Repayments of project loan facilities | ||
| Proceeds from Nemaska supply agreement prepayment | ||
| Capital contribution from noncontrolling interest - Nemaska Lithium | ||
| Payment of deposit to customs authorities | ||
| Other financing activities | ||
| Net cash provided by/(used in) financing activities | ||
| Effect of exchange rate changes on cash and cash equivalents | ||
| (Decrease)/increase in Cash and cash equivalents and Restricted Cash | ||
| Cash and cash equivalents, beginning of period | ||
| Cash and cash equivalents, end of period | ||
| Supplemental disclosure for cash flow: | ||
| Cash payments for income taxes, net of refunds | ||
| Cash payments for interest | ||
| Cash payments for Restructuring and other charges | ||
| Cash payments for Separation-related charges | ||
| Accrued capital expenditures | ||
| Accrued investment in unconsolidated affiliates | ||
| Non-cash assumption of QLP Note | ||
| Non-cash investment in unconsolidated affiliate | ||
| Operating lease right-of-use assets and lease liabilities recorded for ASC 842 |
Loading...
